Review

huvec umbilical vein endothelial cells (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC huvec umbilical vein endothelial cells
Huvec Umbilical Vein Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4966 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/huvec/Primary+Umbilical+Vein+Endothelial+Cells%3B+Normal%2C+Human/pm42276073-409-0-5
Average 99 stars, based on 4966 article reviews

huvec umbilical vein endothelial cells - by Bioz Stars, 2026-10

99/100 stars

Images

Cell Culture:

Article Title: Magnesium oxide-containing radiopaque polyurethane for infection-resistant catheter applications.
Article Snippet: .. HUVECs (PCS-100-010, ATCC) were cultured in human large vessel endothelial cell basal medium, supplemented with large vessel endothelial supplement (LVES) according to the manufacturer's instructions and with 10% (v/v) fetal bovine serum (FBS) (Gibco, USA) and 1% (v/v) penicillin- streptomycin (Pen/Strep) (Biowest, France). ..

Tube Formation Assay:

Article Title: An Injectable Clinical-Grade Fibrin Hydrogel Restores Fertility in Intrauterine Adhesions via MSC-Mediated Immune and Regenerative Modulation, Unlocking an Equivalent Cell-Free EV-Based Therapy.
Article Snippet: While mesenchymal stem cells (MSCs) and extracellular vesicles (EVs) hold therapeutic potential, their clinical translation is hindered by suboptimal delivery systems.. This study presents a directly translatable strategy for treating intrauterine adhesions (IUA) using a clinical-grade, injectable fibrin hydrogel (Porcine Fibrin Sealant, PFS) to deliver MSCs/EVs.. This platform not only ensures biocompatibility and surgical handling but also provides a protective niche.

Incubator:

Article Title: Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction.
Article Snippet: 1 Cardiovascular Medicine, Xinxiang Central Hospital, No. 56 Jinsui Avenue, Weibin District, Henan 453000, China Abstract Background Endothelial dysfunction is the initiating factor in atherosclerosis and is a persistent feature throughout the entire course of acute myocardial infarction (AMI).. Circular RNA (circRNA) fulfils a vital regulatory role in cardiovascular diseases, including AMI.. Aim To investigate the expression and clinical significance of circ_0089762 in AMI, and to elucidate the molecular mechanism in regulating hypoxia/reoxygenation (H/R)-induced damage in human umbilical vein endothelial cells (HUVECs).